Archive: displayed by CME articles

Top

Continuing medical education

Nature Clinical Practice has partnered with Medscape, LLC and Vanderbilt University School of Medicine to provide the opportunity to earn Category 1 AMA PRA Credits™ for selected articles each month. Medscape, LLC and Vanderbilt University School of Medicine are accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other health-care professionals completing any of these activities will be issued a certificate of participation.

There are no fees for participating in or receiving credit for these online educational activities. To complete the questions online and earn continuing medical education credit, you must be a registered user on Medscape.com or have an account in the Vanderbilt CME database.

Medscape logo

If you are not registered on Medscape.com please click on the New Users: Free Registration link on the top left-hand side of the website to register. Registration is free. For questions regarding the content of this activity, contact the accredited provider for this CME activity: cme@medscape.net. For technical assistance, contact cme@webmd.net.

Top

November 2009 Volume 6 No 11

Refractory neuroendocrine tumor—response to liposomal doxorubicin and capecitabine

Gianluca Masi, Lorenzo Fornaro, Samanta Cupini, Fotios Loupakis, Enrico Vasile, Giacomo G. Baldi, Irene Stasi, Lisa Salvatore & Alfredo Falcone

p670 | doi:10.1038/nrclinonc.2009.148

Top

October 2009 Volume 6 No 10

Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer

Seema Panchal, Orli Shachar, Frances O'Malley, Pavel Crystal, Jaime Escallon, Juanita Crook, Anita Bane & Louise Bordeleau

p604 | doi:10.1038/nrclinonc.2009.116

Top

September 2009 Volume 6 No 9

Neoadjuvant polychemotherapy in locally advanced Merkel cell carcinoma

Thomas Jouary, Nathalie Lalanne, François Siberchicot, Anne-Sophie Ricard, Julie Versapuech, Sébastien Lepreux, Michèle Delaunay & Alain Taieb

p544 | doi:10.1038/nrclinonc.2009.109

Top

August 2009 Volume 6 No 8

Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer

Fleur Huang, Yael B. Kushner, Adrian Langleben & William D. Foulkes

p488 | doi:10.1038/nrclinonc.2009.90

Top

July 2009 Volume 6 No 7

A stepwise approach to the management of metastatic midgut carcinoid tumor

Sanjeev Bhattacharyya, Dorothy M. Gujral, Christos Toumpanakis, Gilles Dreyfus, Brian R. Davidson, Joseph Davar & Martyn E. Caplin

p429 | doi:10.1038/nrclinonc.2009.70

Top

June 2009 Volume 6 No 6

Breast cancer and pregnancy: how safe is trastuzumab?

Hatem A. Azim, Jr, Fedro A. Peccatori, Sarah J. Liptrott, Chiara Catania and Aron Goldhirsch

p367 | doi:10.1038/nrclinonc.2009.48

Top

May 2009 Volume 6 No 5

Cerebral primitive neuroectodermal tumor in an adult with a heterozygous MSH2 mutation

Alexander F. Jeans, Ian Frayling, Bharat Jasani, Lucy Side, Claire Blesing and Olaf Ansorge

p295 | doi:10.1038/nrclinonc.2009.35

Top

April 2009 Volume 6 No 4

Restoration of chemosensitivity by bortezomib: implications for refractory myeloma

Chor Sang Chim, Yu Yan Hwang, Clara Pang & Tony W. Shek

p237 | doi:10.1038/nrclinonc.2009.15

Top

March 2009 Volume 6 No 3

Unintended pregnancy during radiotherapy for cancer

Saskia N de Wildt, Nobuko Taguchi and Gideon Koren

p175 | doi:10.1038/ncponc1320

Top

February 2009 Volume 6 No 2

A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer

Raymond W Jang, Mary Doherty, J Jill Hopkins and Ellen Warner

p118 | doi:10.1038/ncponc1294

Top

January 2009 Volume 6 No 1

Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with glioma

Shahriar S Yaghoubi, Michael C Jensen, Nagichettiar Satyamurthy, Shradha Budhiraja, David Paik, Johannes Czernin and Sanjiv S Gambhir

p53 | doi:10.1038/ncponc1278

Top

December 2008 Volume 5 No 12

Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib

Alfonso Quintás-Cardama, Alexander J Lazar, Scott E Woodman, Kevin Kim, Merrick Ross and Patrick Hwu

p737 | doi:10.1038/ncponc1251

Top

Extra navigation

Subscribe

Subscribe to Nature Reviews Clinical Oncology

Advertisement